1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ataxia-telangiectasia (AT) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Oral tablets 1.2.3 Injections 1.3 Market by Application 1.3.1 Global Ataxia-telangiectasia (AT) Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Pharmacy 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ataxia-telangiectasia (AT) Treatment Market Perspective (2017-2028) 2.2 Ataxia-telangiectasia (AT) Treatment Growth Trends by Region 2.2.1 Ataxia-telangiectasia (AT) Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Ataxia-telangiectasia (AT) Treatment Historic Market Size by Region (2017-2022) 2.2.3 Ataxia-telangiectasia (AT) Treatment Forecasted Market Size by Region (2023-2028) 2.3 Ataxia-telangiectasia (AT) Treatment Market Dynamics 2.3.1 Ataxia-telangiectasia (AT) Treatment Industry Trends 2.3.2 Ataxia-telangiectasia (AT) Treatment Market Drivers 2.3.3 Ataxia-telangiectasia (AT) Treatment Market Challenges 2.3.4 Ataxia-telangiectasia (AT) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ataxia-telangiectasia (AT) Treatment Players by Revenue 3.1.1 Global Top Ataxia-telangiectasia (AT) Treatment Players by Revenue (2017-2022) 3.1.2 Global Ataxia-telangiectasia (AT) Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Ataxia-telangiectasia (AT) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Ataxia-telangiectasia (AT) Treatment Revenue 3.4 Global Ataxia-telangiectasia (AT) Treatment Market Concentration Ratio 3.4.1 Global Ataxia-telangiectasia (AT) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ataxia-telangiectasia (AT) Treatment Revenue in 2021 3.5 Ataxia-telangiectasia (AT) Treatment Key Players Head office and Area Served 3.6 Key Players Ataxia-telangiectasia (AT) Treatment Product Solution and Service 3.7 Date of Enter into Ataxia-telangiectasia (AT) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ataxia-telangiectasia (AT) Treatment Breakdown Data by Type 4.1 Global Ataxia-telangiectasia (AT) Treatment Historic Market Size by Type (2017-2022) 4.2 Global Ataxia-telangiectasia (AT) Treatment Forecasted Market Size by Type (2023-2028) 5 Ataxia-telangiectasia (AT) Treatment Breakdown Data by Application 5.1 Global Ataxia-telangiectasia (AT) Treatment Historic Market Size by Application (2017-2022) 5.2 Global Ataxia-telangiectasia (AT) Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Ataxia-telangiectasia (AT) Treatment Market Size (2017-2028) 6.2 North America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) 6.3 North America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Ataxia-telangiectasia (AT) Treatment Market Size (2017-2028) 7.2 Europe Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) 7.3 Europe Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Size (2017-2028) 8.2 Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Ataxia-telangiectasia (AT) Treatment Market Size (2017-2028) 9.2 Latin America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) 9.3 Latin America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Size (2017-2028) 10.2 Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Ataxia-telangiectasia (AT) Treatment Introduction 11.1.4 Sanofi Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Intrabio Ltd 11.2.1 Intrabio Ltd Company Detail 11.2.2 Intrabio Ltd Business Overview 11.2.3 Intrabio Ltd Ataxia-telangiectasia (AT) Treatment Introduction 11.2.4 Intrabio Ltd Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.2.5 Intrabio Ltd Recent Development 11.3 Intas Pharmaceuticals Ltd 11.3.1 Intas Pharmaceuticals Ltd Company Detail 11.3.2 Intas Pharmaceuticals Ltd Business Overview 11.3.3 Intas Pharmaceuticals Ltd Ataxia-telangiectasia (AT) Treatment Introduction 11.3.4 Intas Pharmaceuticals Ltd Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.3.5 Intas Pharmaceuticals Ltd Recent Development 11.4 Sun Pharmaceutical Industries Ltd 11.4.1 Sun Pharmaceutical Industries Ltd Company Detail 11.4.2 Sun Pharmaceutical Industries Ltd Business Overview 11.4.3 Sun Pharmaceutical Industries Ltd Ataxia-telangiectasia (AT) Treatment Introduction 11.4.4 Sun Pharmaceutical Industries Ltd Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.4.5 Sun Pharmaceutical Industries Ltd Recent Development 11.5 Cipla Inc 11.5.1 Cipla Inc Company Detail 11.5.2 Cipla Inc Business Overview 11.5.3 Cipla Inc Ataxia-telangiectasia (AT) Treatment Introduction 11.5.4 Cipla Inc Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.5.5 Cipla Inc Recent Development 11.6 Eli Lilly and Company 11.6.1 Eli Lilly and Company Company Detail 11.6.2 Eli Lilly and Company Business Overview 11.6.3 Eli Lilly and Company Ataxia-telangiectasia (AT) Treatment Introduction 11.6.4 Eli Lilly and Company Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.6.5 Eli Lilly and Company Recent Development 11.7 Saol Therapeutics Inc 11.7.1 Saol Therapeutics Inc Company Detail 11.7.2 Saol Therapeutics Inc Business Overview 11.7.3 Saol Therapeutics Inc Ataxia-telangiectasia (AT) Treatment Introduction 11.7.4 Saol Therapeutics Inc Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.7.5 Saol Therapeutics Inc Recent Development 11.8 USV Private Limited 11.8.1 USV Private Limited Company Detail 11.8.2 USV Private Limited Business Overview 11.8.3 USV Private Limited Ataxia-telangiectasia (AT) Treatment Introduction 11.8.4 USV Private Limited Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) 11.8.5 USV Private Limited Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ataxia-telangiectasia (AT) Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Oral tablets Table 3. Key Players of Injections Table 4. Global Ataxia-telangiectasia (AT) Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Ataxia-telangiectasia (AT) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Ataxia-telangiectasia (AT) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Ataxia-telangiectasia (AT) Treatment Market Share by Region (2017-2022) Table 8. Global Ataxia-telangiectasia (AT) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Ataxia-telangiectasia (AT) Treatment Market Share by Region (2023-2028) Table 10. Ataxia-telangiectasia (AT) Treatment Market Trends Table 11. Ataxia-telangiectasia (AT) Treatment Market Drivers Table 12. Ataxia-telangiectasia (AT) Treatment Market Challenges Table 13. Ataxia-telangiectasia (AT) Treatment Market Restraints Table 14. Global Ataxia-telangiectasia (AT) Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Ataxia-telangiectasia (AT) Treatment Market Share by Players (2017-2022) Table 16. Global Top Ataxia-telangiectasia (AT) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ataxia-telangiectasia (AT) Treatment as of 2021) Table 17. Ranking of Global Top Ataxia-telangiectasia (AT) Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Ataxia-telangiectasia (AT) Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Ataxia-telangiectasia (AT) Treatment Product Solution and Service Table 21. Date of Enter into Ataxia-telangiectasia (AT) Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Ataxia-telangiectasia (AT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Ataxia-telangiectasia (AT) Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Ataxia-telangiectasia (AT) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Ataxia-telangiectasia (AT) Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Ataxia-telangiectasia (AT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Ataxia-telangiectasia (AT) Treatment Revenue Market Share by Application (2017-2022) Table 29. Global Ataxia-telangiectasia (AT) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Ataxia-telangiectasia (AT) Treatment Revenue Market Share by Application (2023-2028) Table 31. North America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Sanofi Company Detail Table 42. Sanofi Business Overview Table 43. Sanofi Ataxia-telangiectasia (AT) Treatment Product Table 44. Sanofi Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 45. Sanofi Recent Development Table 46. Intrabio Ltd Company Detail Table 47. Intrabio Ltd Business Overview Table 48. Intrabio Ltd Ataxia-telangiectasia (AT) Treatment Product Table 49. Intrabio Ltd Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 50. Intrabio Ltd Recent Development Table 51. Intas Pharmaceuticals Ltd Company Detail Table 52. Intas Pharmaceuticals Ltd Business Overview Table 53. Intas Pharmaceuticals Ltd Ataxia-telangiectasia (AT) Treatment Product Table 54. Intas Pharmaceuticals Ltd Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 55. Intas Pharmaceuticals Ltd Recent Development Table 56. Sun Pharmaceutical Industries Ltd Company Detail Table 57. Sun Pharmaceutical Industries Ltd Business Overview Table 58. Sun Pharmaceutical Industries Ltd Ataxia-telangiectasia (AT) Treatment Product Table 59. Sun Pharmaceutical Industries Ltd Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 60. Sun Pharmaceutical Industries Ltd Recent Development Table 61. Cipla Inc Company Detail Table 62. Cipla Inc Business Overview Table 63. Cipla Inc Ataxia-telangiectasia (AT) Treatment Product Table 64. Cipla Inc Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 65. Cipla Inc Recent Development Table 66. Eli Lilly and Company Company Detail Table 67. Eli Lilly and Company Business Overview Table 68. Eli Lilly and Company Ataxia-telangiectasia (AT) Treatment Product Table 69. Eli Lilly and Company Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 70. Eli Lilly and Company Recent Development Table 71. Saol Therapeutics Inc Company Detail Table 72. Saol Therapeutics Inc Business Overview Table 73. Saol Therapeutics Inc Ataxia-telangiectasia (AT) Treatment Product Table 74. Saol Therapeutics Inc Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 75. Saol Therapeutics Inc Recent Development Table 76. USV Private Limited Company Detail Table 77. USV Private Limited Business Overview Table 78. USV Private Limited Ataxia-telangiectasia (AT) Treatment Product Table 79. USV Private Limited Revenue in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) & (US$ Million) Table 80. USV Private Limited Recent Development Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Global Ataxia-telangiectasia (AT) Treatment Market Share by Type: 2021 VS 2028 Figure 2. Oral tablets Features Figure 3. Injections Features Figure 4. Global Ataxia-telangiectasia (AT) Treatment Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Pharmacy Case Studies Figure 7. Others Case Studies Figure 8. Ataxia-telangiectasia (AT) Treatment Report Years Considered Figure 9. Global Ataxia-telangiectasia (AT) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Ataxia-telangiectasia (AT) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Ataxia-telangiectasia (AT) Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global Ataxia-telangiectasia (AT) Treatment Market Share by Players in 2021 Figure 13. Global Top Ataxia-telangiectasia (AT) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ataxia-telangiectasia (AT) Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Ataxia-telangiectasia (AT) Treatment Revenue in 2021 Figure 15. North America Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Ataxia-telangiectasia (AT) Treatment Market Share by Country (2017-2028) Figure 17. United States Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Ataxia-telangiectasia (AT) Treatment Market Share by Country (2017-2028) Figure 21. Germany Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Ataxia-telangiectasia (AT) Treatment Market Share by Region (2017-2028) Figure 29. China Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Ataxia-telangiectasia (AT) Treatment Market Share by Country (2017-2028) Figure 37. Mexico Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Ataxia-telangiectasia (AT) Treatment Market Share by Country (2017-2028) Figure 41. Turkey Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Ataxia-telangiectasia (AT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Sanofi Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 44. Intrabio Ltd Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 45. Intas Pharmaceuticals Ltd Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 46. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 47. Cipla Inc Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 48. Eli Lilly and Company Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 49. Saol Therapeutics Inc Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 50. USV Private Limited Revenue Growth Rate in Ataxia-telangiectasia (AT) Treatment Business (2017-2022) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Sanofi Intrabio Ltd Intas Pharmaceuticals Ltd Sun Pharmaceutical Industries Ltd Cipla Inc Eli Lilly and Company Saol Therapeutics Inc USV Private Limited